Related Experiment Video
Updated: Jan 12, 2026

A Data-Driven Approach to Quantifying Immune States in Sepsis
Published on: February 7, 2025
Comparison of fully-vaccinated and non/partially-vaccinated critically-ill COVID-19 patients in terms of disease
Guillaume Louis1,2, Vincent Dinot3, Thibaut Belveyre4
1Intensive Care Unit, Mercy Hospital, Metz-Thionville Central Regional Hospital, Metz, France. guillaume.louis@chr-metz-thionville.fr.
Background:
Critical care admissions due to breakthrough COVID-19 in fully vaccinated patients remain rare. There is limited data on their characteristics and outcomes compared to non- or partially vaccinated patients, and no studies have evaluated the impact of variants of concern.
Method:
This study used the COMETE-19 (COVID-19 patients in the intensive care unit [ICU]) near real-time prospective registry, a tool launched on March 1, 2020, to track patient and disease characteristics as well as the disease course of critically ill COVID-19 patients in two French ICUs. Fully vaccinated patients were compared with non- or partially vaccinated patients. The primary outcome was a composite criterion of severity, including invasive mechanical ventilation (IMV), other organ assistance, or death. Differences between the vaccinated and control groups regarding other outcomes, patient variables, management, and SARS-CoV-2 variants were explored using univariate analysis. Factors associated with high disease severity in both groups were examined using logistic regression analysis.
Results:
A total of 805 patients (median age, 65 years [IQR 56-71], 67% male) were enrolled. Of these, 41 (5%) were fully vaccinated. Fully vaccinated patients required less frequent IMV (27% vs. 51%, p = 0.003) and had lower mortality (15% vs. 26%, p = 0.026). Full vaccination status was associated with lower disease severity (OR 0.30; CI95% [0.11-0.74]; p = 0.011) and tended to prevent ICU mortality (OR 0.39, CI95% [0.13-1.04], p = 0.072). Variants-of-concern did not associate with outcomes.
Conclusion:
Among critically ill COVID-19 patients, full vaccination was associated with less severe disease progression compared to partial or no vaccination.
Trial Registration:
Clinical Trial: NCT04430322.
More Related Videos
06:29Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
05:39Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
Published on: May 26, 2023
Related Concept Videos
Bioavailability Study Design: Healthy Subjects Versus Patients
Bias in Epidemiological Studies
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pneumonia III: Complications and Assessment
Acute Coronary Syndrome III: Diagnostic Studies
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...